质子泵抑制剂联合酚磺乙胺治疗上消化道出血护理的应用-当代护理-CSCIED科技核心评价数据库-手机版

质子泵抑制剂联合酚磺乙胺治疗上消化道出血护理的应用

Application of proton pump inhibitor combined with sulfamethoxazole in the treatment of upper gastrointestinal bleeding

ES评分 0 浏览量：607 下载量：0

DOI	10.12208/j.cn.20210132
刊名	当代护理 Contemporary Nursing
年，卷(期)	2021, 2(6)
作者	王然明,赖丽,罗燕,陈华双*,
作者单位	成都老年康疗院东虹老年病医院四川成都 ;
摘要	研究上消化道出血护理采取质子泵抑制剂、酚磺乙胺一同治疗后产生的效果。方法研究对象：70例上消化道出血患者。研究时间：2020年2月到2021年2月。研究分组方式：随机数表方式。研究分组类别：对照组实施单独质子泵抑制剂治疗，为35例。观察组加入酚磺乙胺治疗，为35例。研究根本目的：对比两组治疗后临床效果、临床指标、治疗前后凝血指标变化以及不良反应发生率。结果和对照组相比较，观察组治疗总有效率明显较高，临床指标情况明显较好，凝血功能明显改善，（P<0.05）为差异显著，有统计学意义。对照组和观察组不良反应发生率无明显差异，（P＞0.05）。结论上消化道出血护理采取质子泵抑制剂、酚磺乙胺一同治疗能够改善患者凝血功能，治疗效果较明显，并且治疗安全性也较高，值得临床重视。
Abstract	Objective: To study the effect of proton pump inhibitor and etamsylate on upper gastrointestinal bleeding. Methods: Subjects: 70 patients with upper gastrointestinal bleeding. Research time: February 2020 to February 2021. Study grouping: random number table. Study grouping category: 35 cases in the control group were treated with proton pump inhibitors alone. 35 cases in the observation group were treated with etamsylate. Basic objective: To compare the clinical effect, clinical indexes, changes of coagulation indexes before and after treatment and the incidence of adverse reactions between the two groups. Results: compared with the control group, the total effective rate of the observation group was significantly higher, the clinical indicators were significantly better, and the coagulation function was significantly improved (p<0.05). There was no significant difference in the incidence of adverse reactions between the control group and the observation group (P > 0.05). Conclusion: Proton pump inhibitor and etamsylate can improve the coagulation function of patients with upper gastrointestinal bleeding. The treatment effect is obvious, and the treatment safety is also high, which is worthy of clinical attention.
关键词	质子泵抑制剂；酚磺乙胺；上消化道出血；应用
KeyWord	Proton Pump Inhibitor; Etamsylate; Upper Gastrointestinal Bleeding; Application
基金项目
页码	76-79

参考文献
相关文献

[1] 孟庆志,张月华,王海舰等.去甲肾上腺素、血凝酶联合质子泵抑制剂治疗对肝硬化合并上消化道出血患者血液流变学及外周血NO、ET的影响[J].中国中西医结合消化杂志,2022,30(02):122-127.

[2] 周玥.质子泵抑制剂联合酚磺乙胺治疗上消化道出血的效果及对凝血指标的影响[J].中国实用医刊,2022, 49(03): 100-103.

[3] 陈晓填,陈虹余.质子泵抑制剂对消化道出血合并痛风患者血尿酸水平的影响[J].黑龙江医药,2021,34(04): 859-861.

[4] 吴伟,叶晓丹,刘剑烽等.酚磺乙胺联合质子泵抑制剂奥美拉唑治疗急性上消化道出血的效果及对患者免疫功能的影响[J].中国医药,2021,16(07):1048-1051.

[5] 黄世明.针对上消化道出血患者予以奥曲肽+质子泵抑制剂治疗的临床效果进行分析[J].智慧健康,2021,7(02): 130-132.

[6] 热孜万古力·克依木.奥曲肽联合质子泵抑制剂治疗非静脉曲张上消化道出血的效果观察[J].临床合理用药杂志,2020,13(20):19-21.

[7] 张焕耀,黄华杰,沈灏.酚磺乙胺对上消化道出血患者临床疗效及FSF、FIB、血小板计数、血小板聚集率水平的影响[J].中国医学创新,2020,17(36):34-37.

[8] 吴伟,叶晓丹,刘剑烽,曾凤兰,赖伟华,戴穗茹.酚磺乙胺联合质子泵抑制剂奥美拉唑治疗急性上消化道出血的效果及对患者免疫功能的影响[J].中国医药, 2021, 16(7): 1048-1051.DOI:10.3760/j.issn.1673-4777.2021.07.021.

引用本文

王然明,赖丽,罗燕,陈华双*. 质子泵抑制剂联合酚磺乙胺治疗上消化道出血护理的应用 [J]. 当代护理. 2021; 2; (6). 76 - 79.

文献评论

相关学者

相关机构